Patents by Inventor Roger A. Kroes

Roger A. Kroes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273629
    Abstract: Methods of treating a disorder associated with elevated NMDAR antibodies in a patient in need thereof are provided comprising, for example, administering to the patient an effective amount of a spiro-?-lactam compound.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Inventors: Joseph R. Moskal, Roger A. Kroes, Torsten M. Madsen
  • Publication number: 20030175734
    Abstract: The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.
    Type: Application
    Filed: July 3, 2002
    Publication date: September 18, 2003
    Applicant: NYXIS Neurotherapies, Inc.
    Inventors: Roger A. Kroes, Joseph R. Moskal, Hirotaka Yamamoto
  • Patent number: 6440676
    Abstract: The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.
    Type: Grant
    Filed: September 25, 2000
    Date of Patent: August 27, 2002
    Assignee: Nyxis NeuroTherapies, Inc.
    Inventors: Roger A. Kroes, Joseph R. Moskal, Hirotaka Yamamoto
  • Patent number: 6194158
    Abstract: The invention is directed towards gene expression characteristic for cancer, in particular brain cancers such as glioblastoma. Compositions, methods and kits encompassing such therein.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: February 27, 2001
    Assignee: NYXIS NeuroTherapies, Inc.
    Inventors: Roger A. Kroes, Joseph R. Moskal, Hirotaka Yamamoto